Kratos (KTOS) reported $302.6 million in revenue for the quarter ended March 2025, representing a year-over-year increase of 9.2%. EPS of $0.12 for the same period compares to $0.11 a year ago.

Kratos Defense & Security Solutions, Inc. KTOS shares declined 5.1% to reach $34.22 on May 8 following the release of its first-quarter 2025 results. The company reported first-quarter 2025 ...

Kratos Defense & Security Solutions reported its first quarter 2025 earnings, showcasing a notable revenue beat with $302.6 million, surpassing the estimated range of $285 million to $295 million.

Aerospace and defense company Kratos (NASDAQ:KTOS) announced better-than-expected revenue in Q1 CY2025, with sales up 9.2% year on year to $302.6 million. On the other hand, next quarter’s revenue ...

Kratos Defense & Security Solutions reported its first quarter 2025 earnings, showcasing a notable revenue beat with $302.6 million, surpassing the estimated range of $285 million to $295 million. The ...

In its first-quarter 2025 investor letter, Baron Discovery Fund highlighted stocks such as Kratos Defense & Security Solutions, Inc. (NASDAQ:KTOS). Kratos Defense & Security Solutions, Inc ...

Cambrian Period creatures known as sea moths seemed alien because of their additional eye, but a study finds anatomical features more in line with modern animals. An artist’s impression of ...

Hello, Yahoo Entertainment readers! My name is Brett Arnold, and I’m a longtime writer and editor at Yahoo who side hustles as a film critic with my podcast. I’m here to recommend what you ...

Whether it’s from a lack of sleep, the strain of allergy season or a long day, our under eyes could all use a little TLC every now and again — and Loops’ latest launch is the pick-me-up you ...

Over-the-counter ophthalmic products were voluntarily recalled due to a manufacturing deviation discovered during a U.S. Food and Drug Administration audit, a notice says. Pharmaceutical ...

Nearly 76,000 cases of eye drops have been recalled nationwide by BRS Analytical Services, a pharmaceutical consulting firm, according to an FDA enforcement report. The urgent recall follows an ...